Etelcalcetide

Chemical formula: C₃₈H₇₃N₂₁O₁₀S₂  Molecular mass: 1,048.26 g/mol  PubChem compound: 71511839

Therapeutic indications

Etelcalcetide is indicated for:

Secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) on haemodialysis therapy

Population group: only adults (18 years old or older)

Etelcalcetide is indicated for the treatment of secondary hyperparathyroidism (SHPT) in adult patients with chronic kidney disease (CKD) on haemodialysis therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Etelcalcetide is contraindicated in the following cases:

Hypocalcaemia

Hypocalcemia

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2019: PARSABIV Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈